The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis

BACKGROUND: Patients with ER-negative breast tumors are among the most difficult to treat and exhibit low survival rates due, in part, to metastasis from the breast to various distal sites. Aryl hydrocarbon receptor (AHR) ligands show promise as antimetastatic drugs for estrogen receptor (ER)-negati...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Un-Ho, Lee, Syng-Ook, Pfent, Catherine, Safe, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226953/
https://www.ncbi.nlm.nih.gov/pubmed/25011475
http://dx.doi.org/10.1186/1471-2407-14-498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226953/
https://www.ncbi.nlm.nih.gov/pubmed/25011475
http://dx.doi.org/10.1186/1471-2407-14-498

Ejemplares similares